Showing results (1-10 of 260) with videos related to
Sort By:
Pageof 26
Gene Therapy|March 15, 2002
Bypassing tumor-specific and bispecific antibodies: triggering of antitumor immunity by expression of anti-FcgammaR scFv on cancer cell surfaceN Gruel, W H Fridman, J L TeillaudImmunology Letters|July 29, 1999
Vav and SLP-76 recruitment by cross-linking of FcgammaRIIa1 in promyelocytic HL-60 cellsH Rouard, S Tamasdan, W H Fridman, et al.Cancer Detection and Prevention|November 26, 1999
Ras and p53 intracellular targeting with recombinant single-chain Fv (scFv) fragments: a novel approach for cancer therapy?O Cochet, N Gruel, W H Fridman, et al.Preparative Biochemistry & Biotechnology|January 5, 2002
Purification of soluble recombinant human FcgammaRII (CD32)N Gruel, J Chapiro, W H Fridman, et al.European Journal of Immunology|January 1, 1990
Regulation of IgG production by suppressor Fc gamma RII+ T hybridomasS Brunati, J Moncuit, W H Fridman, et al.European Journal of Immunology|August 1, 1990
Recombinant interleukin 2-activated natural killer cells regulate IgG2a productionS Amigorena, C Bonnerot, W H Fridman, et al.Nouvelle Revue Francaise D'Hematologie|January 1, 1988
Fc receptors, immunoglobulin-binding factors and B chronic lymphocytic leukemiaW H Fridman, C Mathiot, J Montcuit, et al.Leukemia|September 19, 2014
Anti-CD20 therapy induces a memory Th1 response through the IFN-γ/IL-12 axis and prevents protumor regulatory T-cell expansion in miceC Deligne, A Metidji, W-H Fridman, et al.Journal of Immunological Methods|February 26, 1987
A sensitive method for testing the effect of immunoglobulin binding factor on Ig secretion by hybridoma B cellsS Amigorena, J Moncuit, W H Fridman, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 1, 1993
Effects of low dose total body irradiation (LDTBI) and recombinant human interleukin-2 in miceA Fourquet, J L Teillaud, D Lando, et al.Pageof 26